AVIMOTIN

WIPO WIPO 2009

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke AVIMOTIN wurde als Wortmarke am 28.04.2009 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 19. November 2019

Markenform Wortmarke
Aktenzeichen 1003132
Länder Australien Schweiz China Japan Norwegen Vereinigte Staaten von Amerika (USA)
Basismarke EU Nr. 007360043, 03. November 2008
Anmeldedatum 28. April 2009
Ablaufdatum 28. April 2019

Markeninhaber

Lochhamer Strasse 11
82152 Planegg/Martinsried
DE

Markenvertreter

Josephspitalstr. 15 80331 Munich DE

Waren und Dienstleistungen

05 Pharmaceutical and veterinary preparations for the prevention, treatment and/or diagnosis of diseases, in particular medicines, vaccines, serums and/or test kits for the prevention, treatment and/or diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neuronal tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and/or renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and/or multiple sclerosis, neurodegenerative disorders, in particular Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, schizophrenia, transmissible spongiform encephalopathy, bovine spongiform encephalopathy and/or Creutzfeldt-Jakob disease, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and/or lupus erythematodes, allergic diseases, in particular allergies, allergic rhinitis, hay fever, asthma, atopic eczema and/or insect sting allergies, cardiovascular disorders, in particular hyperlipidaemia, coronary artery disorders, cardiac insufficiency, high blood pressure and/or obesity, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and/or herpes, infectious diseases, in particular viral infections, bacterial infections, parasitic infections and/or fungal infections, and/or ophthalmic disorders, in particular age-dependent macular degeneration, glaucoma and/or retinoblastoma, in particular low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and/or plant extracts; in particular for oral, topical, intravenous and/or subcutaneous administration
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
09. November 2019 2019/45 Gaz Löschung
28. September 2017 2017/40 Gaz US RAW: Total Invalidation
30. September 2010 2013/4 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
21. Januar 2010 2010/3 Gaz JP Ablehnung
23. Dezember 2009 2010/1 Gaz NO Ablehnung
09. November 2009 2009/46 Gaz AU Ablehnung
24. Juli 2009 2009/35 Gaz US Ablehnung
28. April 2009 2009/24 Gaz EM Eintragung

ID: 141003132